{"product_id":"the-8th-joint-actrims-ectrims","title":"The 8th Joint ACTRIMS-ECTRIMS Meeting 2020 (Videos)","description":"The 8\u003csup\u003eth\u003c\/sup\u003e Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, was held in a virtual format from \u003cb\u003e\u003cspan class=\"xn-chron\"\u003eSeptember 11-13, 2020\u003c\/span\u003e\u003c\/b\u003e, with a special encore session featuring \u003cb\u003eLate-Breaking News and a COVID-19 Session on \u003cspan class=\"xn-chron\"\u003eSeptember 26\u003c\/span\u003e.\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003eAt this virtual conference – \u003cb\u003eMSVirtual2020\u003c\/b\u003e – world class scientists, neurologists, clinicians and researchers from around the world presented the latest research, clinical trial outcomes and technology and diagnostic advances in multiple sclerosis (MS).\u003cbr\u003e\u003cbr\u003eKey topics included:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCutting-edge research into the cause of MS, ranging from epigenetics and genetic factors, to defining the intricate immunological and pathological pathways that inform drug discovery and therapeutic interventions.\u003c\/li\u003e\n\u003cli\u003eRadiological advances and machine learning approaches and how these techniques can help us better understand MS.\u003c\/li\u003e\n\u003cli\u003eBiomarkers of disease activity and response to therapy, which is critical for the future of personalized medicine in MS.\u003c\/li\u003e\n\u003cli\u003eThe outcomes of recent clinical trials of new agents and interventions, innovations in symptomatic and rehabilitative therapy, and current research on MS and COVID-19.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eSessions included:\u003c\/strong\u003e\n\u003cbr\u003e\u003col\u003e\n\u003cli\u003eBD01 – DMTs prevent-slow down cognitive impairment in MS\u003c\/li\u003e\n\u003cli\u003eBD02 – DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity\u003c\/li\u003e\n\u003cli\u003eBD03 – Microglia are protective in MS\u003c\/li\u003e\n\u003cli\u003eCS01 – European Charcot Foundation Symposium; How to enhance remyelination in MS\u003c\/li\u003e\n\u003cli\u003eFC01 – Free Communication 1\u003c\/li\u003e\n\u003cli\u003eFC02 – Free Communication 2\u003c\/li\u003e\n\u003cli\u003eFC03 – Free Communication 3\u003c\/li\u003e\n\u003cli\u003eFC04 – Free Communication 4\u003c\/li\u003e\n\u003cli\u003eHT01 – Hot Topic 1- Strategies to promote remyelination\u003c\/li\u003e\n\u003cli\u003eHT02 – Hot Topic 2- Aging and MS\u003c\/li\u003e\n\u003cli\u003eHT03 – Hot Topic 3- Developments in pediatric MS\u003c\/li\u003e\n\u003cli\u003eHT04 – Hot Topic 4- Grey matter pathology\u003c\/li\u003e\n\u003cli\u003eHT05 – Hot Topic 5- Lymphoid follicles and meningeal involvement in MS\u003c\/li\u003e\n\u003cli\u003eHT06 – Hot Topic 6- Global perspectives on NMOSD\u003c\/li\u003e\n\u003cli\u003eHT07 – Hot Topic 7- MOG mediated disease\u003c\/li\u003e\n\u003cli\u003eLB01 – Late Breaking News\u003c\/li\u003e\n\u003cli\u003eMTE01 – CNS in disorders in children\u003c\/li\u003e\n\u003cli\u003eMTE02 – Neuro-ophthalmology of MS\u003c\/li\u003e\n\u003cli\u003eMTE03 – B-cell-directed therapy in MS\u003c\/li\u003e\n\u003cli\u003eMTE04 – Choosing the right MS disease therapy for individual patients\u003c\/li\u003e\n\u003cli\u003eMTE05 – Immune disorders of the CNS other than MS\u003c\/li\u003e\n\u003cli\u003eNS01 – Nurses’ Session 1- Advanced nursing activities\u003c\/li\u003e\n\u003cli\u003eNS02 – Nurses’ Session 2- Unique contributions of MS nursing\u003c\/li\u003e\n\u003cli\u003ePL01 – Plenary Session 1- Welcome and Paty Lecture\u003c\/li\u003e\n\u003cli\u003ePL02 – Plenary Session 2- ACTRIMS-ECTRIMS Lecture and Closing\u003c\/li\u003e\n\u003cli\u003ePS01 – Strategies for disease modification\u003c\/li\u003e\n\u003cli\u003ePS02 – Innate immunity in MS pathology and repair\u003c\/li\u003e\n\u003cli\u003ePS03 – Biomarkers\u003c\/li\u003e\n\u003cli\u003ePS04 – Impact of the environment and lifestyle and MS risk and clinical course\u003c\/li\u003e\n\u003cli\u003ePS05 – Pharmacological management of progressive MS\u003c\/li\u003e\n\u003cli\u003ePS06 – Lymphocyte subsets in MS\u003c\/li\u003e\n\u003cli\u003ePS07 – Radiological advances I (NAIMS-MAGNIMS)\u003c\/li\u003e\n\u003cli\u003ePS08 – Epigenetics and genetic factors\u003c\/li\u003e\n\u003cli\u003ePS09 – Personalized approaches to MS\u003c\/li\u003e\n\u003cli\u003ePS10 – Gut-CNS axis and the microbiome in MS\u003c\/li\u003e\n\u003cli\u003ePS11 – Radiological advances II\u003c\/li\u003e\n\u003cli\u003ePS12 – Sex-related factors in pathogenesis and management\u003c\/li\u003e\n\u003cli\u003ePS13 – Innovations in symptomatic and rehabilitative therapy\u003c\/li\u003e\n\u003cli\u003ePS14 – The impact of MS on neurons and glia\u003c\/li\u003e\n\u003cli\u003ePS15 – Visual outcome measures in MS (IMSVISUAL)\u003c\/li\u003e\n\u003cli\u003ePS16 – Machine learning approaches\u003c\/li\u003e\n\u003cli\u003eSS02 – Special Session- COVID-19\u003c\/li\u003e\n\u003cli\u003eYI01 – Young Investigators 1\u003c\/li\u003e\n\u003cli\u003eYI02 – Young Investigators 2\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954302160994,"sku":"MED-AMB00753","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/8f7b51fa-9c1f-4853-a566-9a83d37dd8de.jpg?v=1779370630","url":"https:\/\/meducourse.com\/products\/the-8th-joint-actrims-ectrims","provider":"Meducourse","version":"1.0","type":"link"}